Kiora Pharmaceuticals Inc: Certificate of Amendment Effects a 1-for-9 Reverse Stock Split of Company's Common Stock
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.